These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 9790114)

  • 21. CD34 expression in desmoplastic melanoma.
    Hoang MP; Selim MA; Bentley RC; Burchette JL; Shea CR
    J Cutan Pathol; 2001 Nov; 28(10):508-12. PubMed ID: 11737519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrent dermatofibrosarcoma protuberans with myxoid and fibrosarcomatous changes paralleled by loss of CD34 expression.
    Sato N; Kimura K; Tomita Y
    J Dermatol; 1995 Sep; 22(9):665-72. PubMed ID: 8537553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Congenital myxoid and pigmented dermatofibrosarcoma protuberans: a case report.
    El Hachem M; Diociaiuti A; Latella E; Zama M; Lambiase C; Giraldi L; Surrenti T; Callea F
    Pediatr Dermatol; 2013; 30(5):e74-7. PubMed ID: 23534369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dermatofibrosarcoma protuberans: a clinicopathological, immunohistochemical, genetic (COL1A1-PDGFB), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumors.
    Llombart B; Monteagudo C; Sanmartín O; López-Guerrero JA; Serra-Guillén C; Poveda A; Jorda E; Fernandez-Serra A; Pellín A; Guillén C; Llombart-Bosch A
    J Am Acad Dermatol; 2011 Sep; 65(3):564-575. PubMed ID: 21570152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibrosarcomatous dermatofibrosarcoma protuberans with myofibroblastic differentiaion: a histologically distinctive variant [corrected].
    O'Connell JX; Trotter MJ
    Mod Pathol; 1996 Mar; 9(3):273-8. PubMed ID: 8685227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case of recurrent dermatofibrosarcoma protuberans.
    Mingazzini P; Cavallaro G; Amato D; Addesso M; Cavallaro A
    Anticancer Res; 1998; 18(4B):2843-7. PubMed ID: 9713472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myoid differentiation in dermatofibrosarcoma protuberans and its fibrosarcomatous variant: clinicopathologic analysis of 5 cases.
    Calonje E; Fletcher CD
    J Cutan Pathol; 1996 Feb; 23(1):30-6. PubMed ID: 8720984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ALK-rearranged, CD34-positive spindle cell neoplasms resembling dermatofibrosarcoma protuberans: a study of seven cases.
    Agrawal S; Ameline B; Folpe AL; Azzato E; Astbury C; Mentzel T; Knapp C; Rütten A; Creytens D; Sukov W; Baumhoer D; Billings SD; Fritchie KJ
    Histopathology; 2024 Oct; 85(4):649-659. PubMed ID: 38867577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Case of pigmented dermatofibrosarcoma protuberans with atrophic change.
    Taura M; Wada M; Kataoka Y; Ueda Y; Takenaka H; Katoh N; Asai J
    J Dermatol; 2016 Oct; 43(10):1231-1232. PubMed ID: 27029004
    [No Abstract]   [Full Text] [Related]  

  • 30. Tenascin differentiates dermatofibroma from dermatofibrosarcoma protuberans: comparison with CD34 and factor XIIIa.
    Kahn HJ; Fekete E; From L
    Hum Pathol; 2001 Jan; 32(1):50-6. PubMed ID: 11172295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic significance of fibrosarcomatous transformation in dermatofibrosarcoma protuberans.
    Abbott JJ; Oliveira AM; Nascimento AG
    Am J Surg Pathol; 2006 Apr; 30(4):436-43. PubMed ID: 16625088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atrophic dermatofibrosarcoma protuberans: a clinicopathological study of 16 cases.
    Xu S; Zhao L; Wang J
    Pathology; 2019 Oct; 51(6):615-620. PubMed ID: 31447095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dermatofibrosarcoma Protuberans of Distal Extremities and Acral Sites: A Clinicopathologic Analysis of 27 Cases.
    Shah KK; McHugh JB; Folpe AL; Patel RM
    Am J Surg Pathol; 2018 Mar; 42(3):413-419. PubMed ID: 29240584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case of pigmented dermatofibrosarcoma protuberans (Bednar tumor).
    Akasaka T; Ohyama N; Kon S
    J Dermatol; 1997 Jun; 24(6):390-4. PubMed ID: 9241967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dermatofibrosarcoma protuberans association with nuchal-type fibroma.
    Diwan AH; Horenstein MG
    J Cutan Pathol; 2004 Jan; 31(1):62-6. PubMed ID: 14675287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An unusual presentation of dermatofibrosarcoma protuberans: A case of fibrosarcomatous dermatofibrosarcoma protuberans with pleomorphic angiectatic tumor-like changes.
    Yoshida KI; Fujii J; Honma K; Nakai S
    J Cutan Pathol; 2024 Aug; 51(8):609-613. PubMed ID: 38711216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurofibromatous changes in dermatofibrosarcoma protuberans: a potential pitfall in the diagnosis of a serious cutaneous soft tissue neoplasm.
    Kovarik CL; Hsu MY; Cockerell CJ
    J Cutan Pathol; 2004 Aug; 31(7):492-6. PubMed ID: 15239679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [An uncommon malignancy of the breast: dermatofibrosarcoma protuberans with fibrosarcomatous transformation (DFSP-FS)].
    Ledniczky G; Bognár G; Diczházi C; Bereczky B; Barabás L; Ondrejka P
    Magy Seb; 2009 Feb; 62(1):27-9. PubMed ID: 19218166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential expression of HMGA1 and HMGA2 in dermatofibroma and dermatofibrosarcoma protuberans: potential diagnostic applications, and comparison with histologic findings, CD34, and factor XIIIa immunoreactivity.
    Li N; McNiff J; Hui P; Manfioletti G; Tallini G
    Am J Dermatopathol; 2004 Aug; 26(4):267-72. PubMed ID: 15249855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dermatofibrosarcoma protuberans with atrophic appearance at early stage of the tumor.
    Hanabusa M; Kamo R; Harada T; Ishii M
    J Dermatol; 2007 May; 34(5):336-9. PubMed ID: 17408444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.